Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Harold C. Simmons Comprehensive Cancer Center | Researchclopedia

Back to institutions

Harold C. Simmons Comprehensive Cancer Center

Dallashealthcare

976

Works

154,577

Citations

185

h-index

Top Research Topics

Cancer Genomics and Diagnostics Lung Cancer Treatments and Mutations Toxin Mechanisms and Immunotoxins

Top Researchers

Gordon B. Mills Baylor College of Medicine

3,472 works263,330 citationsh-index: 231

Recent Research

Determinants of pancreatic tropism in metastatic renal cell carcinoma

Haitao Xu,Payal Kapur,et al.

20260 citations

CAR-T cell therapy research

Global Cancer Incidence and Screening

Colorectal Cancer Screening and Detection

Advanced Breast Cancer Therapies

Cancer Immunotherapy and Biomarkers

Lymphoma Diagnosis and Treatment

Renal cell carcinoma treatment

Childhood Cancer Survivors' Quality of Life

Genetic factors in colorectal cancer

Adi F. Gazdar Weatherford College

1,239 works114,848 citationsh-index: 161

John D. Minna Weatherford College

2,275 works113,941 citationsh-index: 174

Ignacio I. Wistuba Moffitt Cancer Center

2,829 works104,146 citationsh-index: 153

Philipp E. Scherer The University of Texas Southwestern Medical Center

704 works95,634 citationsh-index: 151

Roy S. Herbst Yale New Haven Hospital

1,328 works92,846 citationsh-index: 134

A phase II study bolstering outcomes by optimizing immunotherapy strategies with evolocumab and nivolumab in patients with metastatic renal cell carcinoma (BOOST-RCC).

T. Zhang,Rebecca Slack Tidwell,et al.

20260 citations

NCCN Guidelines® Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2026

William G. Wierda,Jennifer Brown,et al.

20260 citations

Updated efficacy results from the phase 1 study of gotistobart (BNT316/ONC-392) in combination with lutetium Lu 177 vipivotide tetraxetan (Lu 177) in patients with metastatic castration-resistant prostate cancer (mCRPC).

David R. Wise,Tian Zhang,et al.

20260 citations

Circulating kidney injury marker-1 (KIM-1) in metastatic renal cell carcinoma with divergent histologies (RCCdh): Biomarker analysis of the CAN-I trial.

Wenxin Xu,Clara Steiner,et al.

20260 citations

Vaginal Cancer, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology

Nadeem R Abu-Rustum,Susana M. Campos,et al.

20260 citations